{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-041877","form_type":"8-K","ticker":"OBIO","cik":"0001814114","company_name":"Orchestra BioMed Holdings, Inc.","filed_at":"2022-07-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.138872+00:00","generated_at":"2026-06-24T08:17:26.460080+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Shareholders approve extension of business combination deadline to Nov 2022","bullets":["Extension Proposal approved: 15,084,246 for, 1,365,812 against, 0 abstain.","Deadline extended from Aug 6, 2022 to Nov 6, 2022, with option for monthly extensions to Feb 6, 2023.","Proxies received for 80.4% of 20,450,000 outstanding shares, quorum present.","Adjournment Proposal not needed due to sufficient votes for Extension Proposal."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-041877","json":"https://secwatch.observer/filing/0001213900-22-041877.json","markdown":"https://secwatch.observer/filing/0001213900-22-041877.md","text":"https://secwatch.observer/filing/0001213900-22-041877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1814114/000121390022041877/0001213900-22-041877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1814114/000121390022041877/ea163407-8k_healthsci2.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T08:17:26.460080+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}